Anticoagulant and anti-thrombotic treatments in the management of hematological malignancies in a home care program | Zendy

Pasquale Niscola | Zendy; Andrea Tendas | Zendy; Luca Cupelli | Zendy; Laura Scaramucci | Zendy; Massimiliano Palombi | Zendy; MalgorzataMonika Trawinska | Zendy; Marco Giovannini | Zendy; G Brunetti | Zendy; Claudio Cartoni | Zendy; Francesco Bondanini | Zendy; Paolo de Fabritiis | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Anticoagulant and anti-thrombotic treatments in the management of hematological malignancies in a home care program

Author(s) -

Pasquale Niscola,

Andrea Tendas,

Luca Cupelli,

Laura Scaramucci,

Massimiliano Palombi,

MalgorzataMonika Trawinska,

Marco Giovannini,

G Brunetti,

Claudio Cartoni,

Francesco Bondanini,

Paolo de Fabritiis

Publication year - 2011

Publication title -

indian journal of palliative care

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.395

H-Index - 26

eISSN - 1998-3735

pISSN - 0973-1075

DOI - 10.4103/0973-1075.78450

Subject(s) - medicine , warfarin , anticoagulant , adverse effect , heparin induced thrombocytopenia , low molecular weight heparin , cohort , population , heparin , thrombosis , intensive care medicine , atrial fibrillation , environmental health

Anticoagulants (AC) and anti-platelet (AP) agents are widely administered to patients with hematological malignancies (HM). However, HM patients may be at high risk of bleeding and hemorrhagic complications, because of different form of coagulopathies and several degrees of thrombocytopenia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research